Crossmark

Echocardiographic assessment of recovery of right ventricular function in patients with transthyretin cardiac amyloidosis after one-year tafamidis administration

Crossref DOI link: https://doi.org/10.1007/s10554-025-03444-4

Published Online: 2025-06-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Demirci, Murat https://orcid.org/0000-0002-8835-9557
Oguz, Mustafa https://orcid.org/0000-0002-5165-1212
License Information

Text and Data Mining valid from 2025-06-28

Version of Record valid from 2025-06-28
More Information

Article History

Received: 28 February 2025

Accepted: 13 June 2025

First Online: 28 June 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below